Early DCE-MRI Changes after Longitudinal Registration May Predict Breast Cancer Response to Neoadjuvant Chemotherapy. - Xia Li; Lori R. Arlinghaus; A. Bapsi Chakravarthy; Jaime Farley; Ingrid A. Mayer; Vandana G. Abramson; Mark C. Kelley; Ingrid M. Meszoely; Julie Means-Powell; Thomas E. Yankeelov (WBIR, 2012)

Research and applications: Machine learning for predicting the response of breast cancer to neoadjuvant chemotherapy. - Subramani Mani; Yukun Chen 001; Xia Li; Lori R. Arlinghaus; A. Bapsi Chakravarthy; Vandana G. Abramson; Sandeep R. Bhave; Mia A. Levy; Hua Xu 001; Thomas E. Yankeelov (J. Am. Medical Informatics Assoc., 2013)

Predicting response before initiation of neoadjuvant chemotherapy in breast cancer using new methods for the analysis of dynamic contrast enhanced MRI (DCE MRI) data. - Joseph B. DeGrandchamp; Jennifer G. Whisenant; Lori R. Arlinghaus; Vandana G. Abramson; Thomas E. Yankeelov; Julio Cárdenas-Rodríguez (Biomedical Applications in Molecular, Structural, and Functional Imaging, 2016)